Literature DB >> 10551826

A bipartite nuclear localization signal is required for p53 nuclear import regulated by a carboxyl-terminal domain.

S H Liang1, M F Clarke.   

Abstract

Abnormal p53 cellular localization has been considered to be one of the mechanisms that could inactivate p53 function. To understand the regulation of p53 cellular trafficking, we have previously identified two p53 domains involved in its localization. A basic domain, Lys(305)-Arg(306), is required for p53 nuclear import, and a carboxyl-terminal domain, namely the cytoplasmic sequestration domain (CSD) from residues 326-355, could block the nuclear import of Lys(305) or Arg(306) mutated p53. To characterize further the function of these two domains, we demonstrate in this report that the previously described major nuclear localization signal works together with Lys(305)-Arg(306) to form a bipartite and functional nuclear localization sequence (NLS) for p53 nuclear import. The CSD could block the binding of p53 to the NLS receptor, importin alpha, and reduce the efficiency of p53 nuclear import in MCF-7, H1299, and Saos-2 cells. The blocking effect of the CSD is not due to the enhancement of nuclear export or oligomerization of the p53. These results indicate that the CSD can regulate p53 nuclear import by controlling access of the NLS to importin alpha binding.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10551826     DOI: 10.1074/jbc.274.46.32699

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

Review 1.  Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress.

Authors:  M Ljungman
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

2.  Baculovirus transregulator IE1 requires a dimeric nuclear localization element for nuclear import and promoter activation.

Authors:  Victoria A Olson; Justin A Wetter; Paul D Friesen
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

3.  Protein kinase Cα (PKCα) regulates p53 localization and melanoma cell survival downstream of integrin αv in three-dimensional collagen and in vivo.

Authors:  Stephen D Smith; Martin Enge; Wenjie Bao; Minna Thullberg; Tânia D F Costa; Helene Olofsson; Behxhet Gashi; Galina Selivanova; Staffan Strömblad
Journal:  J Biol Chem       Date:  2012-07-06       Impact factor: 5.157

4.  Critical role of N-terminal end-localized nuclear export signal in regulation of activating transcription factor 2 (ATF2) subcellular localization and transcriptional activity.

Authors:  Chih-Chao Hsu; Chang-Deng Hu
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

5.  G2E3 is a nucleo-cytoplasmic shuttling protein with DNA damage responsive localization.

Authors:  William S Brooks; Sami Banerjee; David F Crawford
Journal:  Exp Cell Res       Date:  2006-12-14       Impact factor: 3.905

6.  Genetic analysis of p53 nuclear importation.

Authors:  Q Li; R R Falsey; S Gaitonde; V Sotello; K Kislin; J D Martinez
Journal:  Oncogene       Date:  2007-06-18       Impact factor: 9.867

7.  MSL2 promotes Mdm2-independent cytoplasmic localization of p53.

Authors:  Jan-Philipp Kruse; Wei Gu
Journal:  J Biol Chem       Date:  2008-11-25       Impact factor: 5.157

8.  Nucleocytoplasmic shuttling of p53 is essential for MDM2-mediated cytoplasmic degradation but not ubiquitination.

Authors:  Kevin O'Keefe; Huiping Li; Yanping Zhang
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

9.  ROCK-dependent phosphorylation of NUP62 regulates p63 nuclear transport and squamous cell carcinoma proliferation.

Authors:  Masaharu Hazawa; De-Chen Lin; Akiko Kobayashi; Yan-Yi Jiang; Liang Xu; Firli Rahmah Primula Dewi; Mahmoud Shaaban Mohamed; Mitsutoshi Nakada; Makiko Meguro-Horike; Shin-Ichi Horike; H Phillip Koeffler; Richard W Wong
Journal:  EMBO Rep       Date:  2017-12-07       Impact factor: 8.807

10.  Hsf1 is required for the nuclear translocation of p53 tumor suppressor.

Authors:  Qiang Li; Rebecca A Feldman; Vijayababu M Radhakrishnan; Steven Carey; Jesse D Martinez
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.